207 related articles for article (PubMed ID: 36325600)
1. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
Tarle M; Müller D; Raguž M; Lukšić I
Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma.
Tarle M; Raguž M; Muller D; Lukšić I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982894
[TBL] [Abstract][Full Text] [Related]
3. Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma.
Dalley AJ; Pitty LP; Major AG; Abdulmajeed AA; Farah CS
Cancer Med; 2014 Apr; 3(2):273-83. PubMed ID: 24415717
[TBL] [Abstract][Full Text] [Related]
4. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
[TBL] [Abstract][Full Text] [Related]
5. Oral erythroplakia and oral erythroplakia-like oral squamous cell carcinoma - what's the difference?
Öhman J; Zlotogorski-Hurvitz A; Dobriyan A; Reiter S; Vered M; Willberg J; Lajolo C; Siponen M
BMC Oral Health; 2023 Nov; 23(1):859. PubMed ID: 37957684
[TBL] [Abstract][Full Text] [Related]
6. Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder.
Lorenzo-Pouso AI; Lafuente-Ibáñez de Mendoza I; Pérez-Sayáns M; Pérez-Jardón A; Chamorro-Petronacci CM; Blanco-Carrión A; Aguirre-Urízar JM
J Oral Pathol Med; 2022 Aug; 51(7):585-593. PubMed ID: 35488780
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
[TBL] [Abstract][Full Text] [Related]
8. Overestimated risk of transformation in oral lichen planus.
Cai X; Zhang J; Zhang H; Li T
Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
[TBL] [Abstract][Full Text] [Related]
9. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus.
Shi P; Liu W; Zhou ZT; He QB; Jiang WW
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):844-9. PubMed ID: 20200437
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
12. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
13. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
[TBL] [Abstract][Full Text] [Related]
16. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
17. Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development.
Feng JQ; Mi JG; Wu L; Ma LW; Shi LJ; Yang X; Liu W; Zhang CP; Zhou ZT
Oral Oncol; 2012 Sep; 48(9):848-52. PubMed ID: 22525603
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
